Cromos Pharma, where the patients are

R&D Trends

University of Maryland School of Medicine, MRIGlobal collaborate

Monday, March 17, 2014 01:39 PM

MRIGlobal and the University of Maryland School of Medicine will collaborate in the development of clinical specimen repositories, laboratory services for clinical trials and research opportunities. The work will be performed under the collaboration agreement by MRIGlobal Dx, a division of MRIGlobal.

More... »

CRF Health eCOA webinar series

Five Prime Therapeutics, Bristol-Myers Squibb collaborate

Monday, March 17, 2014 01:37 PM

Five Prime Therapeutics, a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, and Bristol-Myers Squibb (BMS) have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies directed toward targets identified in two undisclosed immune checkpoint pathways using Five Prime’s proprietary target discovery platform.

More... »

Northwestern Memorial HealthCare, Cadence Health pursue merger

Friday, March 14, 2014 10:26 AM

Cadence Health and Northwestern Memorial HealthCare (NMHC) have agreed to discuss forming an integrated academic healthcare delivery system. Cadence Health is the corporate parent of Central DuPage Hospital and Delnor Hospital, and NMHC owns Northwestern Memorial Hospital and Northwestern Lake Forest Hospital.

More... »

ClinicalRM awarded BARDA contract

Thursday, March 13, 2014 12:57 PM

Clinical Research Management (ClinicalRM), a full-service CRO providing support for basic and applied research, clinical trials and regulatory support, has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA). With this contract award, ClinicalRM becomes part of a clinical studies network being established by BARDA to support development of vaccines, drugs and diagnostics, known as medical countermeasures, needed to protect health and potentially save lives in public health emergencies. The network will provide clinical services in support of adequate and well-controlled phase I through IV clinical trials or trials during a public health emergency, and will support the evaluation of chemical, biological, radiological, nuclear, pandemic influenza and emerging infectious disease medical countermeasures.

More... »

New IMI project to incorporate real-life data into drug development

Thursday, March 13, 2014 12:54 PM

The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways to integrate data from real-life settings, such as clinics, into drug development in Europe. This will assist healthcare decision makers in choosing how best to grant patients access to a new treatment and help pharmaceutical companies make better decisions during drug development.

More... »

Report: Generic drugs slow spending growth

Thursday, March 13, 2014 12:09 PM

Last year, $29.3 billion was spent on prescription drugs in Canada, but the annual growth rate was the second-lowest in more than 20 years, according to a new report by the Canadian Institute for Health Information(CIHI).

More... »

Kythera acquires ATX-101 rights from Bayer Consumer Care

Thursday, March 13, 2014 12:05 PM

Kythera Biopharmaceuticals has acquired all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat (double chin). In 2010, Kythera licensed the commercial rights to ATX-101 outside of the U.S. and Canada to Bayer Consumer Care.

More... »

Scripps Wellderly genome resource now available to researchers

Wednesday, March 12, 2014 02:56 PM

Scientists exploring the genetic causes of illnesses such as Alzheimer's disease, heart disease, cancer and diabetes now have a new tool—a reference DNA dataset built by researchers at Scripps Translational Science Institute (STSI). The Scripps Wellderly Genome Resource (SWGR) is comprised of the whole genome sequences of 454 participants in the Wellderly Study, an ongoing STSI research project that is searching for the genetic secrets behind lifelong health by looking at the genes of healthy elderly people.

More... »

NIH awards Seattle BioMed $9.8M to develop HIV/AIDS vaccine

Wednesday, March 12, 2014 02:54 PM

Seattle BioMed, an independent, nonprofit organization focused solely on infectious disease research, has received a seven-year Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a vaccine that would elicit broadly neutralizing antibodies against HIV-1.

More... »

MAHSC, Roche partner

Wednesday, March 12, 2014 01:50 PM

Researchers and clinicians from Manchester Academic Health Science Center (MAHSC), a partnership involving the University of Manchester and six NHS Trusts, have launched a major partnership with global pharmaceutical company Roche. The new relationship will boost clinical research studies, which could lead to the development of new drugs and diagnostic tools and give patients in the region greater access to new treatments in development.

More... »

CenterWatch Drugs in Clinical Trials



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs